Latest filing published 12 Feb 2018 for InMed Pharmaceuticals Inc., €35k.
Filing timeline
BuySaleInsider track record
Adam Cutler: trading record in brief
Adam Cutler discloses dealings in InMed Pharmaceuticals Inc. to SEC (Form 4). Between 12 January 2018 and 6 February 2018, the trades on record add up to 3 filings.
The open-market record consists of 3 sales worth €265k, with no purchase.
On 12 February 2018 came the latest disclosure, an open-market sale for €35k in InMed Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Adam Cutler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ CA$1.08613.2% of flowCommon SharesTSXSEDI:3132073
- 50,000 shares@ CA$1.172614.5% of flowCommon SharesTSXSEDI:3128671
- 212,500 shares@ CA$1.362972.3% of flowCommon SharesTSXSEDI:3118822
3 of 3 declarations
